“Plaintiffs Eisai R&D Management Co., Ltd., Eisai Co., Ltd., Eisai Manufacturing Ltd., Eisai Inc. (collectively, “Eisai”), and MSD International Business GmbH (together with Eisai, “Plaintiffs”), and defendant Torrent Pharmaceuticals Ltd. (“Torrent”), together the parties in the above-captioned action, have agreed to terms and conditions representing a negotiated settlement of this action and have set forth those terms and conditions in a Settlement Agreement (“Settlement Agreement”). Now the parties, by their respective undersigned attorneys, hereby stipulate and consent to entry of judgment and an injunction in this action as follows: IT IS this ___ day of ___________, 2025: ORDERED, ADJUDGED AND DECREED as follows: 1. This District Court has jurisdiction over the subject matter of the above action and has personal jurisdiction over the parties. 2. As used in this Consent Judgment, (i) the term “Torrent Product” shall mean the drug products sold, offered for sale or distributed pursuant to Abbreviated New Drug Application No. 219352 (and defined in greater detail in the Settlement Agreement); (ii) the term “Generic Equivalent” shall mean a drug product containing lenvatinib that is the subject of an ANDA that refers to NDA No. 206947 as the reference-listed drug (and defined in greater detail in the Settlement Agreement), and (iii) the term “Affiliate” shall mean, with respect to a Party, any entity or person that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with such Party. For purposes of this definition, “control” means (a) ownership, directly or through one or more intermediaries, of (i) more than fifty percent (50%) of the shares of stock entitled to vote for the election of directors, in the case of a corporation, or (ii) more than fifty percent (50%) of the equity interests in the case of any other type of legal entity or status as a general partner in any partnership, or (b) any other arrangement whereby an entity or person has the right to elect a majority of the board of directors or equivalent governing body of a corporation or other entity or the right to direct the management and policies of a corporation or other entity. 3. Torrent, for itself and its Affiliates, acknowledges and agrees that United States Patent Numbers 10,407,393 and 11,186,547 are valid and enforceable with respect to the Torrent Product and any Generic Equivalent, and one or more claims thereof would be infringed by the manufacture, use, sale, offer to sell, importation or distribution of the Torrent Product in the United States. 4. Except as specifically authorized pursuant to the Settlement Agreement, Torrent, including any of its Affiliates, successors and assigns, is enjoined from making, having made, using, selling, offering to sell, importing or distributing the Torrent Product prior to the expiration of United States Patent Numbers 10,407,393 and 11,186,547. Compliance with this Consent Judgment may be enforced by Plaintiffs and their successors in interest, or assigns, as permitted by the terms of the Settlement Agreement. 6. This District Court retains jurisdiction to enforce or supervise performance under this Consent Judgment and the Settlement Agreement. 7. Nothing herein prohibits or is intended to prohibit Torrent from maintaining any “Paragraph IV Certification” pursuant to 21 U.S.C. § 355(j)(2)(A)(vii)(IV) or pursuant to 21 C.F.R. § 314.94(a)(12) with respect to United States Patent Numbers 10,407,393 and 11,186,547. 8. All claims, counterclaims, affirmative defenses and demands in this action are hereby dismissed with prejudice and without costs, disbursements or attorneys’ fees to any party.”